US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

20/20 BIOLABS INC

0.3800

-0.0289-7.07%

Post-market: 0.38000.00000.00%18:53 EDT

Volume:65.80K

Turnover:26.12K

Market Cap:4.85M

PE:-0.38

High:0.4274

Open:0.4100

Low:0.3612

Close:0.4089

52wk High:50.00

52wk Low:0.3612

Shares:12.77M

Float Shares:10.85M

Volume Ratio:1.09

T/O Rate:0.61%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9997

EPS(LYR):-0.7600

ROE:-331.22%

ROA:-62.37%

PB:2.99

PE(LYR):-0.50

Loading ...

Overview Company News Filings

20/20 BioLabs to Attend Maxim Growth Summit 2026

20/20 Biolabs Inc : Maxim Group Cuts Target Price to $2 from $5

THOMSON REUTERS

20/20 BioLabs to Host Investor Webinar on FDA Advisory Panel Vote, OneTest Franchise Model

20/20 Biolabs Gets NASDAQ Notice over $2.5 Million Stockholders’ Equity Shortfall

20/20 Biolabs Q2 EPS $(0.26) Misses $(0.06) Estimate, Sales $730.571K Miss $891.000K Estimate

Benzinga Earnings

20/20 Biolabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level

THOMSON REUTERS

HEALWELL AI (AIDX) Receives a Buy from Maxim Group

20/20 BioLabs to Host Investor Webinar on East Asia Business Development Tour

20/20 Biolabs Participates in Bio Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-up Strategy

THOMSON REUTERS

20/20 Biolabs - Evaluating M&a, Licensing, Joint Venture, and Partnership Opportunities in East Asia

THOMSON REUTERS

20/20 Biolabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock

THOMSON REUTERS

20/20 Biolabs says Vermont selects OneTest for firefighter cancer screening, sees about $500,000 revenue from first cohort

20/20 Biolabs cuts shareholder meeting quorum requirement to one-third of shares outstanding

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:36 AM

20/20 Biolabs Shares up 19.5% at $1.44 Premarket After Co's Plans for Ebola, Hantavirus Testing Preparedness

THOMSON REUTERS

BRIEF-20/20 Biolabs Engages Pcr Test Kit Developers For Ebola And Hantavirus Testing

20/20 Biolabs plans contingency rollout of Ebola, hantavirus testing capacity amid outbreaks

20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing IF Outbreak Creates Overflow Demand

THOMSON REUTERS

20/20 Biolabs Inc - Evaluates Repurposing Pcr Equipment for Ebola and Hantavirus Testing

THOMSON REUTERS

20/20 Biolabs Q1 EPS $(0.28) Misses $(0.10) Estimate, Sales $353.375K Miss $779.000K Estimate

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/AIDX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AIDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AIDX\",,,,,undefined,":{"symbol":"AIDX","market":"US","secType":"STK","nameCN":"20/20 BIOLABS INC","latestPrice":0.38,"timestamp":1790971200000,"preClose":0.4089,"halted":0,"volume":65803,"hourTrading":{"tag":"盘后","latestPrice":0.38,"preClose":0.38,"latestTime":"18:53 EDT","volume":2532,"amount":983.0606,"timestamp":1790981601442,"change":0,"changeRate":0,"amplitude":0.026316},"delay":0,"changeRate":-0.07067742724382485,"floatShares":10847300,"shares":12770300,"eps":-0.999676,"marketStatus":"Market Closed","change":-0.0289,"latestTime":"10-02 16:00:00 EDT","open":0.41,"high":0.4274,"low":0.3612,"amount":26118.78141761,"amplitude":0.161898,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.999676,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4089,"preHourTrading":{"tag":"盘前","latestPrice":0.4295,"preClose":0.4089,"latestTime":"09:20 EDT","volume":8261,"amount":3551.0007631999997,"timestamp":1790947216219,"change":0.0206,"changeRate":0.050379,"amplitude":0.051602},"postHourTrading":{"tag":"盘后","latestPrice":0.38,"preClose":0.38,"latestTime":"18:53 EDT","volume":2532,"amount":983.0606,"timestamp":1790981601442,"change":0,"changeRate":0,"amplitude":0.026316},"volumeRatio":1.08861},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AIDX\",,,,,undefined,":{"symbol":"AIDX","floatShares":10847300,"roa":"-62.37%","roe":"-331.22%","lyrEps":-0.759999,"volumeRatio":1.08861,"shares":12770300,"dividePrice":0,"high":0.4274,"amplitude":0.161898,"preClose":0.4089,"low":0.3612,"week52Low":0.3612,"pbRate":"2.99","psRate":"2.38","week52High":50,"institutionHeld":0,"latestPrice":0.38,"eps":-0.999676,"divideRate":0,"volume":65803,"delay":0,"ttmEps":-0.999676,"open":0.41,"prevYearClose":50,"prevWeekClose":0.4347,"prevMonthClose":0.4365,"prevQuarterClose":0.4365,"fiveDayClose":0.4347,"twentyDayClose":0.6115,"sixtyDayClose":0.583},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AIDX\",params:#limit:5,,,undefined,":[{"date":"2026-09-02","symbol":"AIDX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788379200000,"name":null,"time":"Post-Mkt","dateTimestamp":1788321600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AIDX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AIDX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AIDX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AIDX","date":"2026-10-01","current":-0.380123,"percent":0.896104,"low":-75.813841,"twenty":-5.298522,"median":-1.736274,"eighty":-1.095854,"high":-0.82661,"avg":-4.374375,"sd":7.963569,"marketCap":5574237},"quantilePoints":[{"date":"2026-02-20","current":-75.813841,"twenty":-64.065097,"median":-46.44198,"eighty":-28.818864,"marketCap":246781483},{"date":"2026-02-27","current":-12.969412,"twenty":-44.148132,"median":-25.366644,"eighty":-17.267187,"marketCap":42216706},{"date":"2026-03-06","current":-9.85421,"twenty":-31.342746,"median":-15.019766,"eighty":-10.648904,"marketCap":32076419},{"date":"2026-03-13","current":-7.883368,"twenty":-23.904406,"median":-10.776055,"eighty":-8.926007,"marketCap":25661135},{"date":"2026-03-20","current":-5.976101,"twenty":-17.858388,"median":-9.615801,"eighty":-7.966017,"marketCap":19452796},{"date":"2026-03-27","current":-5.499285,"twenty":-16.249978,"median":-8.900577,"eighty":-6.346175,"marketCap":17900711},{"date":"2026-04-02","current":-5.976101,"twenty":-12.969412,"median":-8.614487,"eighty":-5.976101,"marketCap":19452796},{"date":"2026-04-10","current":-5.139333,"twenty":-12.14293,"median":-7.915156,"eighty":-5.590374,"marketCap":19215046},{"date":"2026-04-17","current":-4.804159,"twenty":-10.776055,"median":-6.427806,"eighty":-5.251057,"marketCap":17961891},{"date":"2026-04-24","current":-4.524848,"twenty":-10.617116,"median":-6.13504,"eighty":-5.139333,"marketCap":16917595},{"date":"2026-05-01","current":-4.441054,"twenty":-9.85421,"median":-5.976101,"eighty":-4.846056,"marketCap":16604306},{"date":"2026-05-08","current":-3.8545,"twenty":-9.377393,"median":-5.624299,"eighty":-4.776228,"marketCap":14411284},{"date":"2026-05-15","current":-3.855058,"twenty":-9.027728,"median":-5.348817,"eighty":-4.329329,"marketCap":14413373},{"date":"2026-05-22","current":-2.443886,"twenty":-8.900577,"median":-5.232126,"eighty":-4.245536,"marketCap":12583766},{"date":"2026-05-29","current":-1.957816,"twenty":-8.900577,"median":-5.158442,"eighty":-3.904776,"marketCap":10080951},{"date":"2026-06-05","current":-1.791711,"twenty":-8.671705,"median":-5.064547,"eighty":-3.826569,"marketCap":9225662},{"date":"2026-06-12","current":-1.772339,"twenty":-8.156743,"median":-4.908901,"eighty":-3.670154,"marketCap":9125914},{"date":"2026-06-18","current":-1.329048,"twenty":-7.985089,"median":-4.804159,"eighty":-2.114441,"marketCap":6843374},{"date":"2026-06-26","current":-1.216525,"twenty":-7.908798,"median":-4.776228,"eighty":-1.973458,"marketCap":6263984},{"date":"2026-07-02","current":-1.256094,"twenty":-7.476484,"median":-4.524848,"eighty":-1.791753,"marketCap":6467726},{"date":"2026-07-10","current":-1.201481,"twenty":-6.690818,"median":-4.32919,"eighty":-1.733182,"marketCap":6186520},{"date":"2026-07-17","current":-1.091843,"twenty":-6.38699,"median":-4.273467,"eighty":-1.338858,"marketCap":5621987},{"date":"2026-07-24","current":-1.05516,"twenty":-6.313052,"median":-4.115237,"eighty":-1.263471,"marketCap":5433102},{"date":"2026-07-31","current":-0.82661,"twenty":-6.230403,"median":-3.896396,"eighty":-1.231405,"marketCap":4256283},{"date":"2026-08-07","current":-0.931302,"twenty":-5.976101,"median":-3.8545,"eighty":-1.207466,"marketCap":4795349},{"date":"2026-08-14","current":-1.233904,"twenty":-5.976101,"median":-3.784811,"eighty":-1.186107,"marketCap":6353471},{"date":"2026-08-21","current":-1.083215,"twenty":-5.925241,"median":-3.686913,"eighty":-1.157297,"marketCap":6298340},{"date":"2026-08-28","current":-1.36104,"twenty":-5.709084,"median":-2.283285,"eighty":-1.157297,"marketCap":7913756},{"date":"2026-09-04","current":-1.343031,"twenty":-5.644654,"median":-2.019642,"eighty":-1.159606,"marketCap":7809040},{"date":"2026-09-11","current":-1.186875,"twenty":-5.590374,"median":-1.983886,"eighty":-1.16008,"marketCap":6901071},{"date":"2026-09-18","current":-1.03555,"twenty":-5.499285,"median":-1.874816,"eighty":-1.143169,"marketCap":6021197},{"date":"2026-09-25","current":-0.92925,"twenty":-5.348817,"median":-1.786559,"eighty":-1.131618,"marketCap":5403115},{"date":"2026-10-01","current":-0.95868,"twenty":-5.298522,"median":-1.736274,"eighty":-1.095854,"marketCap":5574237}],"updateTime":1790982531125},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AIDX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672271460","title":"20/20 BioLabs to Attend Maxim Growth Summit 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672271460","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672271460?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:31","pubTimestamp":1790944275,"startTime":"0","endTime":"0","summary":"20/20 BioLabs to Attend Maxim Growth Summit 202620/20 BioLabs will attend the Maxim Growth Summit 2026 on Oct. 13-14 in New York.Management will hold one-on-one meetings with institutional investors o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7mDVWl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NDAQ","SG9999014021.USD","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","AIDX","BK4198","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","BK4112","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","BCDF","LU0314104364.USD","SG9999014039.USD","SG9999014013.SGD","LU2095319765.USD","BK4588","IE00BN0W2V16.EUR","SG9999014005.SGD","IE00BN0W2W23.USD","LU2210150020.SGD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672371169","title":"20/20 Biolabs Inc : Maxim Group Cuts Target Price to $2 from $5","url":"https://stock-news.laohu8.com/highlight/detail?id=2672371169","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672371169?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:58","pubTimestamp":1790942322,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O150:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671921462","title":"20/20 BioLabs to Host Investor Webinar on FDA Advisory Panel Vote, OneTest Franchise Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2671921462","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671921462?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:31","pubTimestamp":1790685113,"startTime":"0","endTime":"0","summary":"20/20 BioLabs to host investor webinar on FDA advisory panel vote, OneTest franchise model20/20 BioLabs will host an investor webinar on Oct. 7, 2026 at 12:00 p.m. ET.Management plans to discuss the S","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL530ZW4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014039.USD","IE00B64PRP62.GBP","AIDX","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","LU0314104364.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","SG9999014021.USD","NDAQ","IE00BN0W2V16.EUR","LU2210149790.SGD","SG9999014005.SGD","BK4198","BK4588","LU2095319765.USD","IE00BQXX3F31.USD","BCDF","BK4585","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666151584","title":"20/20 Biolabs Gets NASDAQ Notice over $2.5 Million Stockholders’ Equity Shortfall","url":"https://stock-news.laohu8.com/highlight/detail?id=2666151584","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666151584?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:12","pubTimestamp":1789071125,"startTime":"0","endTime":"0","summary":"20/20 Biolabs gets Nasdaq notice over $2.5 million stockholders’ equity shortfall20/20 Biolabs received Nasdaq notices for failing continued listing standards, raising delisting risk if deficiencies a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL2BwZ2T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660587480","title":"20/20 Biolabs Q2 EPS $(0.26) Misses $(0.06) Estimate, Sales $730.571K Miss $891.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2660587480","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660587480?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:40","pubTimestamp":1786970406,"startTime":"0","endTime":"0","summary":"20/20 Biolabs (NASDAQ:AIDX) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.06) by 333.33 percent. This is a 52.94 percent decrease over losses of $(0.17) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61244419/20-20-biolabs-q2-eps-0-26-misses-0-06-estimate-sales-730-571k-miss-891-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487779","title":"20/20 Biolabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487779","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487779?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:31","pubTimestamp":1786969860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nTUAB6BHST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903769","title":"HEALWELL AI (AIDX) Receives a Buy from Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903769","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658903769?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:56","pubTimestamp":1786449387,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Allen Klee reiterated a Buy rating on HEALWELL AI yesterday and set a price target of C$2.00. The company’s shares closed yeste...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/healwell-ai-aidx-receives-a-buy-from-maxim-group-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/healwell-ai-aidx-receives-a-buy-from-maxim-group-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AIPO","CHAT","ARTY","QTOC","AIDX","AGIX","BK4198","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655187741","title":"20/20 BioLabs to Host Investor Webinar on East Asia Business Development Tour","url":"https://stock-news.laohu8.com/highlight/detail?id=2655187741","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655187741?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:33","pubTimestamp":1785414828,"startTime":"0","endTime":"0","summary":"20/20 BioLabs to host investor webinar on East Asia business development tour20/20 BioLabs will host an investor webinar on Aug. 5, 2026 at 12:00 p.m. ET.CEO Jonathan Cohen will discuss commercial opp","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL763Cp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BKPKM429.USD","SG9999014039.USD","LU0314104364.USD","IE00BN0W2W23.USD","LU2095319765.USD","LU2210149790.SGD","BK4198","SG9999014021.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BCDF","BK4585","SG9999014005.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","NDAQ","BK4112","AIDX","IE00BN0W2V16.EUR","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654202846","title":"20/20 Biolabs Participates in Bio Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-up Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2654202846","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654202846?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:30","pubTimestamp":1785184200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA72Z9FM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654028466","title":"20/20 Biolabs - Evaluating M&a, Licensing, Joint Venture, and Partnership Opportunities in East Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=2654028466","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654028466?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:30","pubTimestamp":1785184200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA72Z9FM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653404007","title":"20/20 Biolabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2653404007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653404007?lang=en_us&edition=fundamental","pubTime":"2026-07-23 20:31","pubTimestamp":1784809860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nTUA6FCVQ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638500748","title":"20/20 Biolabs says Vermont selects OneTest for firefighter cancer screening, sees about $500,000 revenue from first cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2638500748","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638500748?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:32","pubTimestamp":1779885177,"startTime":"0","endTime":"0","summary":"20/20 Biolabs won a Vermont firefighter cancer-screening contract for its OneTest multi-cancer blood test, covering up to 4,500 firefighters.First cohort testing through end-2026 targets about one-third of eligible firefighters, expected to generate about $500,000 in testing revenue.Contract includes options for Vermont to renew for up to two additional 12-month periods.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL1b2Y5Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIDX","IE00BN0W2T93.GBP","SG9999014013.SGD","IE00B64PRP62.GBP","NDAQ","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","BK4588","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4198","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4585","SG9999014021.USD","LU2210150020.SGD","LU2095319765.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638528853","title":"20/20 Biolabs cuts shareholder meeting quorum requirement to one-third of shares outstanding","url":"https://stock-news.laohu8.com/highlight/detail?id=2638528853","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638528853?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:29","pubTimestamp":1779827365,"startTime":"0","endTime":"0","summary":"20/20 Biolabs amended its bylaws to cut the stockholder meeting quorum to one-third of outstanding shares from a majority.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 20/20 Biolabs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL40882p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637317877","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:36 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2637317877","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637317877?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:36","pubTimestamp":1779456965,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:36 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nAQN2M058P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637314035","title":"20/20 Biolabs Shares up 19.5% at $1.44 Premarket After Co's Plans for Ebola, Hantavirus Testing Preparedness","url":"https://stock-news.laohu8.com/highlight/detail?id=2637314035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637314035?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:02","pubTimestamp":1779454974,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z0LN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637314785","title":"BRIEF-20/20 Biolabs Engages Pcr Test Kit Developers For Ebola And Hantavirus Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637314785","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637314785?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:59","pubTimestamp":1779454780,"startTime":"0","endTime":"0","summary":"BRIEF-20/20 Biolabs Engages Pcr Test Kit Developers For Ebola And Hantavirus TestingMay 22 (Reuters) - 20/20 Biolabs Inc AIDX.O:20/20 BIOLABS COMMENCES EMERGENCY PLANNING FOR EBOLA  HANTAVIRUS LAB TES","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z059:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637721311","title":"20/20 Biolabs plans contingency rollout of Ebola, hantavirus testing capacity amid outbreaks","url":"https://stock-news.laohu8.com/highlight/detail?id=2637721311","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637721311?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:31","pubTimestamp":1779453119,"startTime":"0","endTime":"0","summary":"20/20 Biolabs started contingency planning to stand up Ebola and hantavirus PCR testing in its CAP-accredited CLIA lab if outbreak-driven demand exceeds public health lab capacity.Plans include engaging PCR test kit developers globally to line up supply options, aiming to reduce near-term constraints if a rapid scale-up is needed.The company is assessing whether PCR equipment used during the COVID-19 pandemic can be repurposed to speed assay validation and potential deployment.Management framed the effort as a platform-flexible strategy designed to accelerate validation work if public health agencies, researchers, or partners request surge testing support.The initiative does not signal regulatory authorization, clinical availability, or a decision to commercialize Ebola or hantavirus tests.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL4VR05z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","SG9999014039.USD","SG9999014021.USD","IE00BKPKM429.USD","LU2095319765.USD","AIDX","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","BK4112","IE00B3QW5Z07.USD","BK4198","BK4588","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD","LU0314104364.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637117943","title":"20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing IF Outbreak Creates Overflow Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2637117943","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637117943?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:31","pubTimestamp":1779453066,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z059:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637031179","title":"20/20 Biolabs Inc - Evaluates Repurposing Pcr Equipment for Ebola and Hantavirus Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637031179","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637031179?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:31","pubTimestamp":1779453066,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z059:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","AIDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878754","title":"20/20 Biolabs Q1 EPS $(0.28) Misses $(0.10) Estimate, Sales $353.375K Miss $779.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878754","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878754?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:18","pubTimestamp":1779308284,"startTime":"0","endTime":"0","summary":"20/20 Biolabs (NASDAQ:AIDX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.10) by 180 percent. This is a 75 percent decrease over losses of $(0.16) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52704745/2020-biolabs-q1-eps-0-28-misses-0-10-estimate-sales-353-375k-miss-779-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"20/20 Biolabs Q1 EPS $(0.28) Misses $(0.10) Estimate, Sales $353.375K Miss $779.000K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIDX","BK4198"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}]}}